Trump Administration Ends Medicare Part D Subsidies, Potentially Raising Drug Premiums for Millions
The Trump administration has announced it will not renew a temporary subsidy program that helped stabilize premiums for Medicare Part D prescription drug plans. The decision, confirmed by Dr. Mehmet Oz, who oversees the Centers for Medicare and Medicaid Services (CMS), will end a $3.6 billion annual support program, potentially leading to higher costs for millions of seniors in 2027